BTIS
EBS icon

BB&T Investment Services’s Emergent Biosolutions EBS Stock Holding History

BB&T Investment Services’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$2K Hold
50
– – ﹤0.01% 1247
2017
Q3 		$2K Buy
50
+23
+85% +$832 ﹤0.01% 1073
2017
Q2 		$1K Buy
+27
New +$833 ﹤0.01% 1030

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BB&T Investment Services's EBS Position: Q4 2017 in Review

BB&T Investment Services held its Emergent Biosolutions (EBS) position steady in Q4 2017 at 50 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1247.

BB&T Investment Services first reported a position in EBS in Q2 2017 and has held it in 3 quarters since. 238 funds tracked by Wall St. Rank hold EBS as of Q4 2017.

  • BB&T Investment Services held 50 shares of Emergent Biosolutions worth $2K as of Q4 2017.
  • BB&T Investment Services left its Emergent Biosolutions share count unchanged in Q4 2017.
  • Emergent Biosolutions made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #1247 holding.
  • BB&T Investment Services first reported a position in Emergent Biosolutions in Q2 2017 and has held it in 3 quarters since.
  • 238 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.